GEETIKA VERMA: Open Payments
NPI 1487967717 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 22 payments from 6 companies in 2025. Trend: 2023 $352 · 2024 $275 · 2025 $399
Food & beverage: $394Education: $5
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $168 |
| Supernus Pharmaceuticals, Inc. | 5 | $80 |
| Alkermes, Inc. | 3 | $64 |
| Collegium Pharmaceutical, Inc. | 3 | $59 |
| ABBVIE INC. | 1 | $15 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: SPRAVATO, Qelbree, ARISTADA, Jornay PM, INVEGA SUSTENNA, VRAYLAR, INGREZZA.
Industry payments across OK — which companies pay providers there.
